Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors
di Filippo et al., The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgad207
di Filippo et al., Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors, The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgad207
Apr 2023   Source   PDF  
  All Studies   Meta
Retrospective 50 COVID-19 patients with long COVID and 50 matched patients without long COVID, showing lower vitamin D levels associated with long COVID.
di Filippo et al., 13 Apr 2023, retrospective, Italy, peer-reviewed, 7 authors, study period 31 August, 2020 - 30 November, 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
AI generated summary. Current AI models can provide useful summaries for non-experts, but may be inaccurate and have limited ability to analyze larger context such as the entire evidence base for vitamin D.

People with Long COVID had lower levels of vitamin D than people without Long COVID.

This article is about the association between low vitamin D levels and Long COVID syndrome in COVID-19 survivors. Long COVID is a syndrome of persistent symptoms after acute COVID-19. The authors of the article found that people with Long COVID had lower levels of vitamin D than people without Long COVID. They also found that the lower the level of vitamin D, the more likely someone was to have Long COVID.

The authors concluded that vitamin D levels should be evaluated in COVID-19 patients after hospital discharge. They also suggested that vitamin D supplementation could be a preventive strategy for Long COVID.

Here are some of the key findings of the article:

  • People with Long COVID had lower levels of vitamin D than people without Long COVID.
  • The lower the level of vitamin D, the more likely someone was to have Long COVID.
  • Vitamin D levels should be evaluated in COVID-19 patients after hospital discharge.
  • Vitamin D supplementation could be a preventive strategy for Long COVID.

It is important to note that this was a small study, and more research is needed to confirm these findings. However, the results of this study suggest that vitamin D may play a role in the development of Long COVID.

The conclusion of the study matches most other studies. There is a growing body of evidence that suggests that low vitamin D levels may be associated with an increased risk of Long COVID. A meta-analysis of 20 studies, published in 2022, found that people with low vitamin D levels were more likely to develop Long COVID than people with high vitamin D levels. The authors of the meta-analysis concluded that vitamin D supplementation could be a potential preventive strategy for Long COVID. However, some studies have found no association between vitamin D levels and Long COVID. It is also important to note that vitamin D is not a cure for Long COVID.

Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors
Luigi Di Filippo, Stefano Frara, Fabrizio Nannipieri, Alice Cotellessa, Massimo Locatelli, Patrizia Rovere Querini, Andrea Giustina, Prof Andrea Giustina, Pharma S P A Andrea Giustina
Purpose: Long-COVID is an emerging syndrome affecting 50-70% of COVID-19 survivors which still lacks predicting factors. Due to the extra-skeletal effects of vitamin D, we retrospectively assessed in COVID-19 survivors 6-months after hospitalization the association between 25(OH)vitamin D levels and Long-COVID. Methods: Long-COVID was defined according to NICE-guidelines. Fifty Long-COVID and 50 non-Long-COVID subjects matched on a 1:1-basis were enrolled from an outpatient-post-COVID clinic-cohort seen from August to November 2020. Therapies/comorbidities affecting calcium/vitamin-D/bone metabolism, and/or admission in ICU during hospitalization were exclusion criteria. 25(OH)vitamin D was measured at hospital-admission and 6-months after discharge. Results: We observed lower 25(OH)vitamin D levels, evaluated at follow-up, in subjects with Long-COVID than those without (20.1vs23.2 ng/mL-p=0.03). Regarding the affected health-areas evaluated in the entire cohort, we observed lower 25(OH)vitamin D levels in those with neurocognitive symptoms at follow-up (n.7) as compared to those without (n.93) (14.6vs20.6 ng/mL-p=0.042). In patients presenting vitamin D deficiency (<20 ng/mL) both at admission and at follow-up (n.42), those affected by Long-COVID (n.22) presented lower 25(OH)vitamin D levels, at follow-up, compared to those not affected (n.20) (12.7vs15.2 ng/mL-p=0.041). In multiple-regression analyses, lower 25(OH)vitamin D levels, at follow-up, resulted as the only variable significantly associated with Long-COVID in our cohort (p=0.008, OR 1.09-CI 1.01-1.16). Conclusions : COVID-19 survivors with Long-COVID have lower 25(OH)vitamin D levels as compared to matched-patients without Long-COVID. Our data suggest that vitamin D levels should be evaluated in COVID-19 patients after hospital-discharge. Role of vitamin D supplementation as preventive strategy of COVID-19 sequelae should be tested in randomized-controlled trials.
Afzal, Bojesen, Nordestgaard, Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis, Clin Chem
Akbar, Wibowo, Pranata, Setiabudiawan, Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis [published correction appears, Front Nutr
Alkodaymi, Omrani, Fawzy, Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis, Clin Microbiol Infect, doi:10.1016/j.cmi.2022.01.014
Bianconi, Mannarino, Figorilli, Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19, Nutrition, doi:10.1016/j.nut.2021.111408
Bilezikian, Bikle, Hewison, MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19, Eur J Endocrinol, doi:10.1530/EJE-20-0665
Bilezikian, Binkley, Luca, Consensus and Controversial Aspects of Vitamin D and COVID-19
Bogliolo, Cereda, Klersy, Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study, Front Nutr, doi:10.3389/fnut.2022.934258
Bouillon, Marcocci, Carmeliet, Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions, Endocr Rev, doi:10.1210/er.2018-00126
Caballero-García, Pérez-Valdecantos, Guallar, Effect of Vitamin D Supplementation on Muscle Status in Old Patients Recovering from COVID-19 Infection, Medicina (Kaunas), doi:10.3390/medicina57101079
Campi, Gennari, Merlotti, Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis, doi:10.1186/s12879-021-06281-7
Charoenngam, Holick, Immunologic Effects of Vitamin D on Human Health and Disease, Nutrients, doi:10.3390/nu12072097
Chiodini, Gatti, Soranna, Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front Public Health, doi:10.3389/fpubh.2021.736665
Clemente, Sinatti, Cirella, Santini, Balsano, Alteration of Inflammatory Parameters and Psychological Post-Traumatic Syndrome in Long-COVID Patients, Int J Environ Res Public Health, doi:10.3390/ijerph19127103
Di Filippo, Allora, Doga, Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity, J Clin Endocrinol Metab, doi:10.1210/clinem/dgab599
Di Filippo, Compagnone, Frara, Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors, Endocrine, doi:10.1007/s12020-022-03096-7
Di Filippo, Doga, Frara, Giustina, Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications
Di Filippo, Formenti, Doga, Pedone, Rovere-Querini et al., Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes, J Clin Endocrinol Metab, doi:10.1210/clinem/dgaa738
Di Filippo, Frara, Giustina, The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects, Nat Rev Endocrinol, doi:10.1038/s41574-021-00516-y
Di Filippo, Uygur, Locatelli, Nannipieri, Frara et al., Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization
Dissanayake, Silva, Sumanatilleke, Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis, J Clin Endocrinol Metab, doi:10.1210/clinem/dgab892
Dossari, Ahmad, Aljowair, Association of vitamin D with glycemic control in Saudi patients with type 2 diabetes: a retrospective chart review study in an emerging university hospital, J Clin Lab Anal
Ellis, Kelly, Shurlock, Hepburn, The role of vitamin D testing and replacement in fibromyalgia: a systematic literature review, BMC Rheumatol, doi:10.1186/s41927-018-0035-6
Fernandes, Sales, Santos, Caparbo, Murai et al., Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19, Front Nutr, doi:10.3389/fnut.2022.979667
Fernández-De-Las-Peñas, Palacios-Ceña, Gómez-Mayordomo, Cuadrado, Florencio, Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification, Int J Environ Res Public Health, doi:10.3390/ijerph18052621
Filippo, Formenti, Rovere-Querini, Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19, Endocrine, doi:10.1007/s12020-020-02383-5
Galluzzo, Ciciarello, Tosato, Association between vitamin D status and physical performance in COVID-19 survivors: Results from the Gemelli against COVID-19 post-acute care project, Mech Ageing Dev, doi:10.1016/j.mad.2022.111684
Garcia, Seelaender, Sotiropoulos, Coletti, Lancha, Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy, Nutrition, doi:10.1016/j.nut.2018.09.031
Giustina, Adler, Binkley, Consensus statement from 2nd International Conference on Controversies in Vitamin D, Rev Endocr Metab Disord, doi:10.1007/s11154-019-09532-w
Giustina, Bouillon, Binkley, Controversies in Vitamin D: A Statement From the Third International Conference, JBMR Plus, doi:10.1002/jbm4.10417
Giustina, Hypovitaminosis D and the endocrine phenotype of COVID-19, Endocrine, doi:10.1007/s12020-021-02671-8
Gáll, Székely, Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings, Nutrients, doi:10.3390/nu13113672
Haugen, Basnet, Hardang, Vitamin D status is associated with treatment failure and duration of illness in Nepalese children with severe pneumonia, Pediatr Res, doi:10.1038/pr.2017.71
Hussein, Galal, Amin, Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: a cross-sectional study, Eur Rev Med Pharmacol Sci, doi:10.26355/eurrev_202204_28635
Jolliffe, Camargo, Jr, Sluyter, Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(21)00051-6
Kalichuran, Van Blydenstein, Venter, Omar, Vitamin D status and COVID-19 severity, S Afr J Infect Dis, doi:10.4102/sajid.v37i1.359
Khairy, Attia, Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF), Nutr Neurosci, doi:10.1080/1028415X.2019.1665854
Lai, Yang, Sun, Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis, Metabolism, doi:10.1016/j.metabol.2022.155330
Lorenzo, Conte, Lanzani, Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study, PLoS One, doi:10.1371/journal.pone.0239570
Maddaloni, Cavallari, Napoli, Conte, Vitamin D and Diabetes Mellitus, Front Horm Res, doi:10.1159/000486083
Maglietta, Diodati, Puntoni, Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis, J Clin Med, doi:10.3390/jcm11061541
Makrani, Afshari, Ghajar, Forooghi, Moosazadeh, Vitamin D and fibromyalgia: a meta-analysis, Korean J Pain, doi:10.3344/kjp.2017.30.4.250
Mandal, Barnett, Brill, Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Notarte, De Oliveira, Peligro, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis, J Clin Med, doi:10.3390/jcm11247314
Nowaczewska, Wiciński, Osiński, Kaźmierczak, The Role of Vitamin D in Primary Headache-from Potential Mechanism to Treatment, Nutrients, doi:10.3390/nu12010243
Olsson, Saini, Strömberg, Evidence for Vitamin D Receptor Expression and Direct Effects of 1α,25(OH)2D3 in Human Skeletal Muscle Precursor Cells, Endocrinology, doi:10.1210/en.2015-1685
Parra-Ortega, Alcara-Ramírez, Ronzon-Ronzon, 25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City, Nutr Res Pract, doi:10.4162/nrp.2021.15.S1.S32
Plotnikoff, Quigley, Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain, Mayo Clin Proc
Puig-Domingo, Marazuela, Yildiz, Giustina, COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology, Endocrine, doi:10.1007/s12020-021-02734-w
Querini, Lorenzo, Conte, Post-COVID-19 follow-up clinic: depicting chronicity of a new disease, Acta Biomed, doi:10.23750/abm.v91i9-S.10146
Raveendran, Misra, Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management, Diabetes Metab Syndr, doi:10.1016/j.dsx.2021.102235
Rovere-Querini, Tresoldi, Conte, Ruggeri, Ghezzi et al., Biobanking for COVID-19 research, Panminerva Med, doi:10.23736/S0031-0808.20.04168-3
Sempos, Heijboer, Bikle, Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D, Br J Clin Pharmacol, doi:10.1111/bcp.13652
Sivan, Taylor, NICE guideline on long covid, BMJ, doi:10.1136/bmj.m4938
Su, Yuan, Chen, Multiple early factors anticipate post-acute COVID-19 sequelae, Cell, doi:10.1016/j.cell.2022.01.014
Tecilazich, Formenti, Giustina, Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects, Rev Endocr Metab Disord, doi:10.1007/s11154-020-09575-4
Townsend, Dyer, Mccluskey, Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection, Nutrients, doi:10.3390/nu13072430
Tsur, Feldman, Feldhammer, Hoshen, Leibowitz et al., Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes, Diabetes Care
Wagatsuma, Sakuma, Vitamin D signaling in myogenesis: potential for treatment of sarcopenia, Biomed Res Int, doi:10.1155/2014/121254
Xie, Al-Aly, Risks and burdens of incident diabetes in long COVID: a cohort study, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(22)00044-4
Zhang, Mei, Zhang, Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis, BMC Med, doi:10.1186/s12916-022-02656-y
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop